Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report [Yahoo! Finance]
MITSUBISHI CH GRP U/ADR (MTLHY)
NASDAQ:AMEX Investor Relations:
mitsubishichem-hd.co.jp/english/ir
Company Research
Source: Yahoo! Finance
Current treatment regimens focus on symptom management and preventing the progression of the disease, but early diagnosis and intervention are crucial due to the progressive nature of the disease. Some of the emerging drug candidates for Scleroderma treatment include MT-0551 by Mitsubishi Tanabe Pharma Corporation, FT011 by Certa Therapeutics, and AM1476 by AnaMar AB, with some reaching as far as Phase III of clinical trials, signifying an unrelenting commitment to research and innovation within the scientific community. Strategic collaborations, licensing efforts, mergers and acquisitions are shaping the future of Scleroderma research and drug development, signaling a concentrated and collaborative effort across the pharmaceutical industry to bring forward novel treatments for this chronic condition. The Scleroderma drug pipeline report for 2024 has provided a complete analysis of the advancements in treatment options for Scleroderma, with over 45 companies globally involved, i
Show less
Read more
Impact Snapshot
Event Time:
MTLHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MTLHY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MTLHY alerts
High impacting MITSUBISHI CH GRP U/ADR news events
Weekly update
A roundup of the hottest topics
MTLHY
News
- Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS [Yahoo! Finance]Yahoo! Finance
- Classiq, Deloitte Tohmatsu, and Mitsubishi Chemical Compress Quantum Circuits by Up to 97% [Yahoo! Finance]Yahoo! Finance
- Government of Canada announces investment in Québec-based Aramis Biotechnologies [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group [Yahoo! Finance]Yahoo! Finance